TopFunds

MetLife

NYSE: MET

Stock price

99.44 USD

(+0%) TODAY

Life & Health InsuranceInsurance - Life
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
4.6
0.7
3.7
4.9
6.1
5.7
7.7
6.3
1.8
5.9
4.8
0.5%
02Free cash flow per share
11.8
13.4
12.2
9.4
14.7
12.6
14.8
14.1
18.7
21.3
27.2
8.7%
03Dividends per share
1.3
1.4
1.5
1.7
1.7
1.8
1.9
2
2.1
2.2
2.2
5.5%
04Dividends payout, %
32.9%
2.2%
45.4%
35.5%
30.9%
34.4%
26.9%
33.7%
1.1%
39%
50.4%
4.4%
PROFIT AND LOSS STATEMENT
05Revenue
$ 61,343
$ 60,527
$ 62,308
$ 67,941
$ 69,620
$ 67,887
$ 63,366
$ 67,965
$ 67,709
$ 69,939
$ 77,084
2.3%
06% Change
-
(1.3)%
2.9%
9%
2.5%
(2.5)%
(6.7)%
7.3%
(0.4)%
3.3%
10.2%
2.3%
07Cost of revenue
(45,175)
(46,572)
(48,846)
(52,041)
(53,431)
(52,418)
(46,531)
(49,029)
(50,420)
(50,940)
(49,060)
0.8%
08Gross profit
16,168
13,955
13,462
15,900
16,189
15,469
16,835
18,936
17,289
18,999
28,024
5.7%
09% Margin
26.4%
23.1%
21.6%
23.4%
23.3%
22.8%
26.6%
27.9%
25.5%
27.2%
36.4%
25.8% A
10Operating expenses
(10,517)
(9,674)
(9,926)
(9,593)
(9,394)
(8,542)
(8,317)
(12,572)
(15,127)
(13,377)
(23,363)
8.3%
11% of Revenue
(17.1)%
(16)%
(15.9)%
(14.1)%
(13.5)%
(12.6)%
(13.1)%
(18.5)%
(22.3)%
(19.1)%
(30.3)%
(17.5)% A
12Operating Income
5,651
4,281
3,536
6,307
6,795
6,927
8,518
6,364
2,162
5,622
4,661
(1.9)%
13Income tax expense
(1,590)
(693)
(1,470)
(1,179)
(886)
(1,509)
(1,642)
(1,062)
(560)
(1,178)
(1,258)
(2.3)%
14Net Income
5,373
850
4,010
5,123
5,899
5,407
6,855
5,284
1,578
4,426
3,379
(4.5)%
15% Margin
8.8%
1.4%
6.4%
7.5%
8.5%
8%
10.8%
7.8%
2.3%
6.3%
4.4%
6.6% A
16Shares Outstanding
1,128,343
1,095,519
1,043,588
1,013,900
944,400
913,200
869,400
808,900
762,431
711,100
664,957
(5.2)%
17EPS Basic
3.5
0.7
3.7
5
6.1
5.7
7.7
6.4
1.8
6
4.8
3.3%
18EPS Diluted
4.6
0.7
3.7
4.9
6.1
5.7
7.7
6.3
1.8
5.9
4.8
0.5%
19EBITDA
7,512
6,090
5,460
8,057
8,380
8,459
10,132
7,975
3,925
7,373
6,475
(1.5)%
% Margin
12.3%
10.1%
8.8%
11.9%
12%
12.5%
16%
11.7%
5.8%
10.5%
8.4%
10.9% A
20Net Interest Income (expense)
(1,168)
(1,157)
(1,129)
(1,122)
(955)
(913)
(920)
(938)
(1,045)
(1,037)
(1,061)
(1)%
21Net Debt / EBITDA
1.1
1.2
1.2
0.1
-
(0.2)
(0.3)
(0.3)
(0.5)
(0.2)
(0.3)
0.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
12,752
12,651
12,701
15,821
16,598
19,795
20,047
20,195
20,639
20,068
22,032
5.6%
23Short-term investments
364,022
298,980
313,801
302,202
331,670
358,713
347,450
293,126
296,194
88,714
103,305
(11.8)%
24Accounts receivable
22,863
15,465
18,423
19,644
20,443
17,870
20,518
22,170
33,784
34,259
54,253
9%
25Other current assets
(399,637)
(327,096)
(344,925)
(337,667)
(368,711)
(396,378)
-
-
-
-
-
-
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
-
-
-
-
-
-
388,015
335,491
350,617
143,041
179,590
-
Non-Current Assets
28Net property, plant & equipment
-
-
-
-
-
-
-
1,926
1,993
1,851
1,698
-
29Long-term investments
371,118
304,116
338,767
322,871
353,830
382,581
147,371
134,826
144,188
346,666
362,806
(0.2)%
30Other non-current assets
(371,118)
(304,116)
(338,767)
(322,871)
(353,830)
(382,581)
224,322
190,829
190,786
185,899
201,072
-
31Total Non-Current Assets
-
-
-
-
-
-
371,693
327,581
336,967
534,416
565,576
-
Total Assets
877,933
898,764
719,892
687,538
740,463
795,146
759,708
663,072
687,584
677,457
745,166
(1.6)%
LIABILITIES
Current Liabilities
32Accounts payable
-
-
-
-
-
-
-
-
-
-
-
-
33Short-term debt
100
242
477
268
235
393
341
175
119
465
1,561
31.6%
34Other current liabilities
(100)
(242)
(477)
(268)
(235)
(393)
262,837
250,908
257,456
257,604
274,578
-
35Total Current Liabilities
-
-
-
-
-
-
263,178
251,083
257,575
258,069
276,139
-
Non-Current Liabilities
36Long-term debt
21,217
19,610
18,830
15,976
16,616
17,756
17,089
17,805
18,709
18,250
18,622
(1.3)%
37Other non-current liabilities
(21,217)
(19,610)
(18,830)
(15,976)
(16,616)
(17,756)
411,692
364,059
381,047
373,435
421,484
-
38Total Non-Current Liabilities
-
-
-
-
-
-
428,781
381,864
399,756
391,685
440,106
-
39Total Liabilities
809,437
831,062
661,022
634,580
674,081
720,329
691,959
632,947
657,331
649,754
716,245
(1.2)%
SHAREHOLDERS` EQUITY
40Common stock
12
12
12
12
12
12
12
12
12
12
12
-
41Retained earnings / (deficit)
35,519
34,683
26,527
28,926
33,078
36,491
41,197
40,332
40,146
42,626
44,290
2.2%
42Accumulated other comprehensive income / (loss)
4,771
5,366
7,427
1,722
13,052
18,072
10,919
(22,621)
(19,242)
(21,186)
(18,084)
-
43Noncontrolling interests
547
171
194
217
238
259
267
244
238
258
523
(0.5)%
44Total shareholders' equity
68,496
67,702
58,870
52,958
66,382
74,817
67,749
30,125
30,253
27,703
28,921
(8.3)%
45Total Liabilities and shareholders' Equity
877,933
898,764
719,892
687,538
740,463
795,146
759,708
663,072
687,584
677,457
745,166
(1.6)%
46Total Debt
21,317
19,852
19,307
16,244
16,851
18,149
17,430
17,980
18,828
18,715
20,183
(0.6)%
47Net Debt
8,565
7,201
6,606
423
253
(1,646)
(2,617)
(2,215)
(1,811)
(1,353)
(1,849)
-
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
5,373
850
4,010
5,123
5,899
5,407
6,855
5,284
1,578
4,426
3,379
(4.5)%
49Depreciation & amortization
693
652
795
628
630
619
694
673
718
714
753
0.8%
50Share-based compensation expense
-
-
-
-
-
-
-
-
-
-
-
-
51Changes in working capital and other assets
7,279
13,161
7,914
3,775
7,396
5,482
5,278
5,416
11,964
9,976
13,973
6.7%
52Net cash flows from operating activities
13,345
14,663
12,719
9,526
13,925
11,508
12,827
11,373
14,260
15,116
18,105
3.1%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
-
-
-
-
-
-
4,360
-
(1,170)
-
-
-
54Purchases of investments / marketable securities
(154,942)
(154,633)
(115,470)
(108,160)
(91,788)
(93,585)
(109,321)
(104,644)
(84,274)
(82,138)
(105,695)
(3.8)%
55Proceeds from maturities of marketable securities
149,762
157,428
101,519
110,131
80,014
79,063
110,792
108,428
76,096
69,937
92,870
(4.7)%
56Other investing activities
(5,218)
(8,645)
(2,925)
(7,605)
(5,812)
(4,047)
(17,018)
(6,404)
(898)
708
(2,782)
(6.1)%
57Net cash flows from investing activities
(10,398)
(5,850)
(16,876)
(5,634)
(17,586)
(18,569)
(11,187)
(2,620)
(10,246)
(11,493)
(15,607)
4.1%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(1,949)
(372)
(2,927)
(2,718)
(2,285)
(193)
(4,803)
(3,326)
(3,103)
(3,207)
(3,883)
7.1%
59Dividends paid, net
(1,769)
(1,839)
(1,820)
(1,819)
(1,821)
(1,859)
(1,842)
(1,783)
(1,764)
(1,727)
(1,703)
(0.4)%
60Debt issuance (repayments), net
2,398
(1,347)
(367)
(1,908)
409
877
(632)
878
875
(982)
(566)
-
61Other financing activities
25
61
4,208
3,644
8,265
11,904
5,902
(5,717)
1,052
2,785
6,315
73.9%
62Net cash flows from financing activities
(1,295)
(3,497)
(906)
(2,801)
4,568
10,729
(1,375)
(9,948)
(2,940)
(3,131)
163
-
63Increase (decrease) in cash and cash equivalents
1,944
(101)
50
3,120
777
3,197
252
148
444
(571)
1,964
0.1%
64Cash and equivalents, ending balance
12,752
17,877
12,701
15,821
16,598
19,795
20,047
20,195
20,639
20,068
22,032
5.6%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
13,345
14,663
12,719
9,526
13,925
11,508
8,467
11,373
13,090
15,116
18,105
3.1%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

MetLife (MET) financial statements and performance

Explore MetLife (MET) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.